A novel anti-fibrotic agent

Back to news

Date Posted: 19/09/2018
Publisher: BiPconnect

Activated hepatic stellate cells (HSCs) play a major role in the development of liver fibrosis and their activation is the target of many anti-fibrotic therapies. However, these approaches have remained ineffective mainly due to an incomplete understanding of the molecular mechanisms underlying HSC activation and the lack of target specificity of candidate drugs.

For more information, please click here

Translate Into English   /   Revert to Original